Roche says Herceptin with Pertuzumab "impressive"

[News]

Roche Holding AG's Herceptin combined with pertuzumab showed"impressive results" in a phase II breast cancer trial, the Swissdrugmaker said on Friday.

More... (http://www.healthcentral.com/breast-cancer/news-253161-66.html)